These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7518319)

  • 1. Transurethral resection of the prostate for benign prostatic hypertrophy: factors associated with a successful outcome at 1 year.
    Doll HA; Black NA; McPherson K
    Br J Urol; 1994 Jun; 73(6):669-80. PubMed ID: 7518319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate.
    Wasson JH; Reda DJ; Bruskewitz RC; Elinson J; Keller AM; Henderson WG
    N Engl J Med; 1995 Jan; 332(2):75-9. PubMed ID: 7527493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of generic measures of health-related quality of life in the assessment of outcome from transurethral resection of the prostate.
    MacDonagh RP; Cliff AM; Speakman MJ; O'Boyle PJ; Ewings P; Gudex C
    Br J Urol; 1997 Mar; 79(3):401-8. PubMed ID: 9117222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study.
    Flanigan RC; Reda DJ; Wasson JH; Anderson RJ; Abdellatif M; Bruskewitz RC
    J Urol; 1998 Jul; 160(1):12-6; discussion 16-7. PubMed ID: 9628595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quality of life of patients on a waiting list for transurethral resection of the prostate.
    Hall JC; Hall JL; McRae PJ
    J Qual Clin Pract; 1996 Jun; 16(2):69-73. PubMed ID: 8794397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up after transurethral resection of the prostate, contact laser prostatectomy, and electrovaporization.
    van Melick HH; van Venrooij GE; Boon TA
    Urology; 2003 Dec; 62(6):1029-34. PubMed ID: 14665349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: analysis of subjective changes, morbidity and mortality.
    van Melick HH; van Venrooij GE; Eckhardt MD; Boon TA
    J Urol; 2003 Apr; 169(4):1411-6. PubMed ID: 12629374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
    Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
    BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality, morbidity and complications following transurethral resection of the prostate for benign prostatic hypertrophy.
    Doll HA; Black NA; McPherson K; Flood AB; Williams GB; Smith JC
    J Urol; 1992 Jun; 147(6):1566-73. PubMed ID: 1375662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing to predict outcome after transurethral resection of the prostate.
    Bruskewitz RC; Reda DJ; Wasson JH; Barrett L; Phelan M
    J Urol; 1997 Apr; 157(4):1304-8. PubMed ID: 9120927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of the effects of prostatectomy on symptoms and quality of life.
    Derrett S; Paul C; Herbison P
    N Z Med J; 2001 Jun; 114(1134):276-9. PubMed ID: 11480508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
    Rosario DJ; Phillips JT; Chapple CR
    J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations of urodynamic changes with changes in symptoms and well-being after transurethral resection of the prostate.
    Van Venrooij GE; Van Melick HH; Eckhardt MD; Boon TA
    J Urol; 2002 Aug; 168(2):605-9. PubMed ID: 12131318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of transurethral prostatectomy in men over 80 years.
    Ilkjaer LB; Lund L; Nielsen KT
    Scand J Urol Nephrol; 1998 Jul; 32(4):270-2. PubMed ID: 9764454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia.
    Cowles RS; Kabalin JN; Childs S; Lepor H; Dixon C; Stein B; Zabbo A
    Urology; 1995 Aug; 46(2):155-60. PubMed ID: 7542818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized study of transurethral resection of the prostate and combined transurethral resection and vaporization of the prostate as a therapeutic alternative in men with benign prostatic hyperplasia.
    Küpeli S; Yilmaz E; Soygür T; Budak M
    J Endourol; 2001 Apr; 15(3):317-21. PubMed ID: 11339401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve Growth Factor Levels are Associated with Overactive Bladder Symptoms and Long-Term Treatment Outcome after Transurethral Resection of the Prostate in Patients with Benign Prostatic Hyperplasia.
    Hu H; Zhang W; Liu X; Wang H; Fang Z; Liang C; Wang T; Xu K
    J Urol; 2018 Sep; 200(3):620-625. PubMed ID: 29630981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in outcome of transurethral resection of the prostate for benign prostatic hypertrophy between three diagnostic categories.
    Doll HA; Black NA; McPherson K; Williams GB; Smith JC
    Br J Urol; 1993 Sep; 72(3):322-30. PubMed ID: 7693294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does transurethral resection of the prostate pose a risk to life? 22-year outcome.
    Koshiba K; Egawa S; Ohori M; Uchida T; Yokoyama E; Shoji K
    J Urol; 1995 May; 153(5):1506-9. PubMed ID: 7536257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.